Amgen Oncology is committed to the relentless pursuit of breakthroughs for cancer patients and their families. Our portfolio features many first-in-class oncology/hematology medicines and innovative therapies for difficult-to-treat cancers.


Live chat

Description
ITP Treatment Product website
SRE Prevention Treatment website
RR Multiple Myeloma Treatment website
https://www.amgenassist360.com
FN Prevention Treatment website
https://www.amgenoncologybiosimilars.com
ALL Treatment Product website
ALL Treatment Product REMS
https://www.Amgenoncology.com
https://www.Amgenmedinfo.com
REMS Fact Sheet.pdf
Handling Guide.pdf
Quick Start Dosing Guide.pdf
All Treatment Prescribing Information.pdf
Continuum of Care Guide.pdf
Product Factsheet.pdf
NGS Considerations for Coverage.pdf
New real world Prospective Data Flashcard.pdf
Resource Guide 1.pdf
Resource Guide 2.pdf
Resource Guide 3.pdf
Update to 2020 Biosimilar Trend Report.pdf
Nurse Checklist.pdf
KRAS G12C- An Emerging Biomarker in NSCLC Slide Deck.pdf
KRAS G12C Biomarker Testing Fact Sheet.pdf
How to Identify KRAS G12C Flashcard.pdf
Amgen First Step booklet.pdf
AA360 HCP Brochure.pdf
MOA Video
MRD Video
Resources
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
United States
Phone: 800-772-6436
Email: medinfo@amgen.com